Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing Drug – Yahoo Finance
|
Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing Drug
Yahoo Finance 2, 2017 /PRNewswire/ — Neovia Oncology, (Beijing, Taiwan, & Seattle), has begun its first Phase 1 clinical trial for its lead cancer drug NEV-801, a novel, multi-inhibitor drug able to enhance immunotherapy response in patients with advanced drug … |
